Skip to main content

Table 1 Summary of the clinical data reported cases of small cell carcinoma of the pancreas

From: Primary small cell carcinoma of the pancreas: rare type of pancreatic cancer and review of the literatures

Ref.

Age

Sex

Location

Treatment

Survival

4

42

M

Body

Symptomatic

1 month

4

67

M

Head

Symptomatic

1 month

4

62

M

Head

Symptomatic

2 months

4

54

M

Head

Symptomatic

2 months

4

73

M

Head

Symptomatic

1 month

5

45

M

Head

Symptomatic

Not stated

5

75

M

Head

Symptomatic

Not stated

6

27-60

3F/3M

Head

Surgery and Chemoradiotherapy

9-173 months

7

50

F

Tail

Symptomatic

2 weeks

8

66

M

Head

Symptomatic, polychemotherapy followed by CDDP VP-16

2 week

12

69

F

Head

Surgery and CDDP, VP-16

6 months

13

62

M

Head

CDDP, Doxorubicin, VP-16

2 month

18

54

M

Head

Polychemotherapy followed by CDDP, VP-16

50 month

19

64

F

Not stated

Carboplatin, etoposide

56 months

19

69

M

Not stated

Carboplatin, etoposide

14 months

19

62

M

Not stated

Carboplatin, etoposide

9 months

19

69

M

Not stated

Carboplatin, etoposide

18 months

20

74

M

Tail

Gemcitabin, PEGylated octreotide, 5-FU

8 months

  1. CDDP: cis-dichlorodiammine platinum; VP-16: etoposide; 5-FU: 5-fluorouracil